Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Ferguson

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 4, 2020
Class III Obesity and Other Factors Associated with Longer Wait Times for Endometrial Cancer Surgery: A Population-Based StudyAndrea N Simpson, Rinku Sutradhar, Sarah E Ferguson, et al.
Gynecologic Oncology|February 10, 2004
Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinomaSarah E Ferguson, Adam B Olshen, Agnès Viale, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in OntarioShiru L Liu, Wing C Chan, Geneviève Bouchard-Fortier, et al.
Gynecologic Oncology|July 18, 2020
Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare systemJeanna M McCuaig, Melanie Care, Sarah E Ferguson, et al.
Psycho-Oncology|March 1, 2012
Psychosexual distress in women with gynecologic cancer: a feasibility study of an online support groupCatherine C Classen, Meredith L Chivers, Sara Urowitz, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 24, 2013
Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologistsClare J Reade, Sarah Finlayson, Jessica McAlpine, et al.
BMJ (Clinical Research Ed.)|December 9, 2021
Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort studyMaria C Cusimano, Maria Chiu, Sarah E Ferguson, et al.
American Journal of Obstetrics and Gynecology|September 26, 2021
Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomyMaria C Cusimano, Sarah E Ferguson, Rahim Moineddin, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2017
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancerTaymaa May, Jocelyn M Stewart, Marcus Q Bernardini, et al.
American Journal of Obstetrics and Gynecology|December 28, 2020
Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based studyMaria C Cusimano, Rahim Moineddin, Maria Chiu, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 4, 2020
Class III Obesity and Other Factors Associated with Longer Wait Times for Endometrial Cancer Surgery: A Population-Based StudyAndrea N Simpson, Rinku Sutradhar, Sarah E Ferguson, et al.
Gynecologic Oncology|February 10, 2004
Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinomaSarah E Ferguson, Adam B Olshen, Agnès Viale, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in OntarioShiru L Liu, Wing C Chan, Geneviève Bouchard-Fortier, et al.
Gynecologic Oncology|July 18, 2020
Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare systemJeanna M McCuaig, Melanie Care, Sarah E Ferguson, et al.
Psycho-Oncology|March 1, 2012
Psychosexual distress in women with gynecologic cancer: a feasibility study of an online support groupCatherine C Classen, Meredith L Chivers, Sara Urowitz, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 24, 2013
Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologistsClare J Reade, Sarah Finlayson, Jessica McAlpine, et al.
BMJ (Clinical Research Ed.)|December 9, 2021
Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort studyMaria C Cusimano, Maria Chiu, Sarah E Ferguson, et al.
American Journal of Obstetrics and Gynecology|September 26, 2021
Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomyMaria C Cusimano, Sarah E Ferguson, Rahim Moineddin, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2017
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancerTaymaa May, Jocelyn M Stewart, Marcus Q Bernardini, et al.
American Journal of Obstetrics and Gynecology|December 28, 2020
Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based studyMaria C Cusimano, Rahim Moineddin, Maria Chiu, et al.
Pageof 14